Mutations in the PRKCSH, SEC63 and LRP5 genes cause autosomal dominant polycystic liver disease (ADPLD). The proteins products of PRKCSH (alias GIIB) and SEC63 function in protein quality control and processing in the endoplasmic reticulum (ER), while LRP5 is implicated in Wnt/b-catenin signaling. To identify common denominators in the PLD pathogenesis, we mapped the PLD interactome by affinity proteomics, employing both HEK293T cells and H69 cholangiocytes. Identification of known complex members, such as glucosidase IIA (GIIA) for PRKCSH, and SEC61A1 and SEC61B for SEC63, confirmed the specificity of the analysis. GANAB, encoding GIIA, was very recently identified as an ADPLD gene. The presence of GIIA in the LRP5 complex pinpoints a potential functional connection with PRKCSH. Interestingly, all three PLD-associated protein complexes included filamin A (FLNA), a multifunctional protein described to play a role in ciliogenesis as well as canonical Wnt signalling. As ciliary dysfunction may also contribute to hereditary liver cyst formation, we evaluated the requirement of PRKCSH and SEC63 for ciliogenesis and Wnt signaling. By CRISPR/Cas9 induced knockdown of both ADPLD genes in HEK293T cells and H69 cholangiocytes, we identified that their depletion results in defective ciliogenesis. However, only H69 knockouts displayed reduced Wnt3a activation. Our results suggest that loss of PRKCSH and SEC63 leads to general defects in ciliogenesis, while quenching of the Wnt signaling cascade is cholangiocyte-restricted. Interactions of all three PLD-associated protein complexes with FLNA may mark a common link between the ADPLD proteins and the cystogenic processes driving this disease.
Introduction a large exome sequencing effort (5) . Cysts frequently display loss-of-heterozygosity (LOH) (6) (7) (8) (9) (10) (11) . Wild-type alleles are completely lost by this process, which appears to be crucial for cyst development.
PRKCSH, SEC63 and GIIA proteins are located in the endoplasmic reticulum (ER), LRP5 on plasma membranes, and polycystin-1 (PC1) and polycystin-2 (PC2), encoded by PKD1 and PKD2 respectively, on the primary cilium (2, 12, 13) . A study on a genetic interaction network between PRKCSH, SEC63, PKD1 and PKD2 implicated PKD1 as the rate limiting component of cyst formation (12) (13) (14) . PRKCSH, also known as glucosidase IIb (GIIB), functions in n-glycan processing through its interaction with GIIA. PRKCSH maintains the complex in the ER through a localization signal (15) . SEC63 is present on the ER membrane in the SEC61 protein translocon, where it facilitates protein translocation and transmembrane protein insertion. Both ER proteins are part of post-translational quality control and processing of PC1 and PC2 (12) (13) (14) , while GIIA was shown to be required for maturation of PC1, and subsequently for correct surface and ciliary localization of both polycystins (4) . Although direct evidence of the suggested function of the polycystins in ciliary calcium trafficking has remained elusive (16, 17) , much credence has been given to the hypothesis that they are important for ciliary function (18) (19) (20) . Intact cilia are important drivers of cyst development (21) . Primary cilia in biliary ducts act as mechano-, osmo-and chemosensors (22) , and structural ciliary abnormalities may be present in cysts (23, 24) . Although it has become clear that PRKCSH/GIIB (and recently GIIA), and SEC63 protein loss leads to defective PC1 processing, resulting in a ciliadependent cyst formation (4, 14) , it remains unclear whether other aspects of cilium formation, cilium structure, or ciliumdirected pathways are also affected.
The polycystin complex has been implicated in MAPK/ERK, mTOR and cAMP pathways (21) , yet disturbance of these pathways is not sufficient to cause cilia-dependent cyst growth. Wnt/b-catenin signaling is another pathway essentially linked to primary cilia function. LRP5, the most recent identified ADPLD gene (2) , implicates Wnt signaling in cystogenesis. Wnt signaling through LRP6, a close homologue of LRP5, is dependent upon n-glycosylation (25) . Similarly, several experimental data link SEC63 to Wnt signaling by binding to nucleoredoxin (26) , a protein that binds to Dishevelled (27) and determines its levels (28) , while the c-terminal tail of polycystin-1 directly associates with beta-catenin, thus regulating canonical Wnt signaling (29) . Finally, primary cilia may restrict the activity of the canonical Wnt pathway by spatial sequestering of betacatenin to the cilium (30, 31) . It remains to be identified if PRKCSH and SEC63 directly interact with Wnt signaling components, and/or if mutations directly affect the Wnt pathway.
In this study we first aimed to unveil the associating functional protein modules and pinpoint the candidate common pathogenic denominators using affinity proteomics. Our results suggest that none of the three PLD-associated proteins (LRP5, PRKCSH and SEC63) plays a direct role in either Wnt signaling or cilium function, as none of the canonical players in these processes were found to interact. However, FLNA, a signaling scaffold protein previously shown to bind to polycystin-2 (PC-2), and to be involved in ciliogenesis as well as canonical Wnt signaling, was present in all three PLD-associated protein complexes. By CRISPR/Cas9 mediated knockdown of LRP5, PRKCSH and SEC63 in HEK293T cells and H69 cholangiocytes, as well as evaluation of patient-derived cells, we determined the importance of these genes for correct ciliogenesis and Wnt signaling.
Results

Tandem affinity proteomics determines the PLD-associated interactome
We performed affinity proteomics to identify putative physical connections between the molecular machinery of PRKCSH, SEC63 and LRP5, and to find molecular clues for the observed abnormalities (Fig. 1 ). Tandem affinity purification followed by mass spectrometry was performed both in H69 cholangiocytes as well as in HEK293T cells. Recently, we and others demonstrated that HEK293T cells are very efficient in assessment of interacting protein complexes and networks, both of the entire cell (32) as well as of a specific organelle such as the cilium (33) . In total, we performed 5 experiments with the full length LRP5 protein, 6 experiments with the LRP5 intracellular domain (ICD), 7 experiments with SEC63, and 19 experiments with PRKCSH, resulting in 2357 TAP-MS identifications (Supplementary Material, Table S1 , Fig. 1 ). PRKCSH TAPs captured 233 proteins, and 94 remained after filtering. SEC63 bait caught 353 prey proteins, 155 of which remained after filtering. LRP5 TAPs captured 371 proteins, and filtering left 119 proteins. Glucosidase IIA (GIIA), the main binding partner of PRKCSH/GIIB, was present in all 19 PRKCSH TAP experiments (Fig. 1) . Five PRKCSH TAPs captured nucleoporin 210 kDa and another five caught peroxisomal biogenesis factor (PEX) 14. SEC63 captured interaction partners SEC61B and SEC61A1 in four of seven experiments, and one SEC63 TAP captured another peroxisomal biogenesis factor, PEX19. Since peroxisomes require the ER for their formation (34), we assessed peroxisome formation in our knockout cells. We found that peroxisome formation was uninhibited as determined by immunofluorescence for PEX14 (Supplementary Material, Fig. S1 ). LRP5 full-length protein did not localize to the primary cilium (Supplementary Material, Fig. S2 ). GIIA was identified to associate to the LRP5 ICD complex in two out of six experiments, without PRKCSH/GIIB being detected. Interestingly, Filamin A (FLNA) was found to interact with all three bait proteins (detected in 9/37 TAP experiments). Although immunofluorescence did not indicate co-localization of FLNA with the bait proteins (data not shown), co-immunoprecipitation confirmed the presence of small amounts of FLNA with SEC63 and LRP5ICD (Fig. 1B) . GIIA was also present with coimmunoprecipitation. These results indicate that LRP5 protein might interact with GIIA, and that all proteins underlying ADPLD might have an interaction with FLNA in common.
PRKCSH and SEC63 TAPs captured mainly ER localized proteins, most of which are implicated in ER protein synthesis, including many ribosomal proteins (Table 1; Supplementary  Material, Table S1 ). Immunofluorescence staining co-localized PRKCSH and SEC63 protein products with protein disulfide isomerase (PDI), a resident enzyme of the ER, without any detectable signal at primary cilia (Fig. 2) , which was in line with our affinity proteomics results.
CRISPR-Cas9 induced knockdown of PRKCSH and SEC63 disrupts ciliogenesis
In order to study the effect of PRKCSH, SEC63 and LRP5 mutations, the genes were knocked out in H69 cholangiocyte and HEK293T cells using CRISPR-Cas9 technology to introduce deletions resulting in loss of protein. All constructs were effective in inducing mutations, albeit with different efficiencies (Supplementary Material, Figs S4 and S5). We subsequently assessed PRKCSH and SEC63 clones expected to have bi-allelic Cilium formation of PRKCSH and SEC63 knockout cells was clearly diminished when compared to controls, for both H69 and HEK293T cells ( Fig. 3A-D showed cilia on 9.0% 6 3.7% of cells, whereas PRKCSH -/-and SEC63 -/-HEK293T displayed cilia on 2.3% 6 1.3% (P ¼ 0.0002) and 4.2% 6 1.9% (P ¼ 0.004) of cells respectively. Evaluation of the cell cycle progression by flow cytometry did not reveal major differences (Fig. 3E , Supplementary Material, Fig. S8 ), although a small shift could be observed of the population of cells in G1 (slightly decreased) to G2 (slightly increased) upon SEC63 knockout, while the percentage of cells in S phase is the same as in WT cells (Fig. 3E) . No significant differences in any cell cycle phase could be observed upon PRKCSH depletion. These data indicate that mutations in the genes underlying ADPLD significantly reduce ciliogenesis.
Knockdown of PRKCSH and SEC63 reduce Wnt signaling in H69 cholangiocytes
Since Wnt signaling is disrupted by LRP5 mutations of ADPLD, and can be affected by mutation of ciliary genes, we assessed Wnt signaling in PRKCSH and SEC63 knockouts using a TCF/LEF1 luciferase reporter assay. Wnt signaling was significantly decreased due to loss of PRKCSH and SEC63 in H69 cholangiocytes in three independent experiments ( Wnt signaling appeared to be clone rather than mutation specific. 
LRP5 glycosylation is not dependent on PRKCSH and SEC63
As a disrupted function of the glucosidase PRKCSH/GIIB (and also GANAB/GIIA that was identified in our TAP dataset) is expected to induce N-glycosylation defects, we evaluated if LRP5 was a substrate affected by CRISPR/Cas9 mediated PRKCSH knockout, and if possibly SEC63 also plays a role in this. Our glycosylation assay showed that LRP5 is similarly glycosylated between WT, PRKCSH -/-and SEC63 -/-HEK293T cells (Fig. 5A ). Endo F and Endo H treatment similarly removed N-glycosylation of LRP5 between the types of cells, as indicated by the reduced molecular weight of the protein on western blot (Fig. 5A) . Interestingly, the LRP5 signal intensities seemed to be decreased in the knockout cells. This was confirmed by evaluation of LRP5 protein levels in relation to b-actin (Fig. 5B) . To evaluate if the reduced levels were caused by a transcriptional downregulation, we assessed the LRP5 mRNA levels in the knockout cells, which were not reduced and even slightly increased (Fig. 5C ). Affinity purification experiments confirm known interactor GIIA for PRKCSH, and SEC61 complex proteins for SEC63, validating the current approach. It shows that PRKCSH and SEC63 interact with PEX14 and PEX19 respectively. The identification of these peroxisomal proteins confirm previous studies. Peroxisomes form in the ER, where they bud off in foci to form mature peroxisomes (34) . PEX14 is localized in the ER near SEC63 when newly formed (35) , and combined SEC62/SEC63 loss impairs peroxisome biogenesis. Although liver cysts may be found in peroxisome biogenesis disorders (36), our findings indicate no further link to ADPLD development. Single loss of PRKCSH or SEC63 did not affect PEX14 presence or localization in our cell lines.
Effects of patient
We were able to discover novel PRKCSH interacting partners, such as NUP210, FLNA and MYO1B, while SEC63 complex interactors include TBL2, TMPO, ARFGAP1, MRS, DNAH7, MTDH and FLNA. No Wnt signaling interactors are present for LRP5 fulllength protein or intracellular domain, but LRP5 was found in a complex with KIF11, PSMD12, FLNA, PPP2CA, PPP2CB, CBX3, PLBD2, CPVL and GIIA.
Several of our findings do further implicate Wnt signaling in hepatic cystogenesis, which pathway has previously been found to cause cyst development (2, 29, 37, 38) . First, the interaction of LRP5-ICD with GIIA points towards n-glycan processing of this part of LRP5. Second, loss of ADPLD genes PRKCSH and SEC63 in H69 cells leads to a small decrease in Wnt signaling, and, third, this small Wnt signaling decrease is similar to that observed for LRP5 mutations present in ADPLD families ((2) and this study). An explanation may be that n-glycosylation of LRP6 is necessary for its maturation and plasma membrane localization (25) . LRP5 processing may be similarly n-glycosylation dependent, which protein displays approximately 71% homology (39) and contains at least four predicted n-glycosylation sites (40-42) (http://www.cbs. dtu.dk/services/NetNGlyc/). It is unknown whether LRP5 maturation and membrane translocation also requires SEC63 and the SEC61 complex, like many transmembrane proteins (43, 44) , but SEC63 has been linked previously to Wnt signaling through nucleoredoxin (26) . Interestingly, GANAB, the gene encoding GIIA, is the most recently identified ADPKD and ADPLD gene (4), and required for maturation of PC1. The N-glycosylation of LRP5 however, that we could observe in HEK293T cells (Fig. 5) was not diminished by depletion of either PRKCSH/GIIB or SEC63, which suggests that LRP5 is not a substrate of Glucosidase II and SEC63 is not involved in the regulation of LRP5 N-glycosylation. Our findings together strengthen the case for Wnt signaling abnormalities as a common contributing factor in hepatic liver cyst development. If this is unrelated to maturation and trafficking of polycystin-1 remains to be identified. The fact that we determined that knock out of either PRKCSH or SEC63 led to reduced protein levels of LRP5, while the transcript levels were not reduced, suggests proteostatic connectivity of the ADPLD-associated pathways downstream of gene transcription.
The cell-line dependent effect of PRKCSH and SEC63 loss on Wnt signaling is a surprising finding. This is either a limitation to the applicability of our findings, especially regarding the use of HEK293T cells to evaluate this as in contrast to the H69 cholangiocytes, this cell line shows variability between different knock out clones. However, it may also point towards a tissuespecific effect of loss of ADPLD genes. In man, PRKCSH and SEC63 mutation only leads to significant cyst development in the liver, and little to no cyst development in the kidney (45) . Another limitation is that ciliary formation did not affect Wnt signaling impairment. Wnt signaling is putatively inhibited by primary cilia (30, 31) , but Wnt signaling was impaired in both proliferative (low cilia formation) and serum-starved (high cilia formation) conditions. Cilium-independent mechanisms, such as those described above, are therefore most likely the cause of the observed Wnt defect.
Filamin A may provide a link between the PLD proteins, ciliogenesis and Wnt signalling. Although with the available reagents no co-localization could be identified with PRKCSH, SEC63 and LRP5, co-immunoprecipitation indicates the protein might link to SEC63 and LRP5. Filamin A is a molecular scaffold protein involved in cell motility and signaling, and interacts with a large number of proteins (46) . The protein is part of the SYSCILIA gold standard protein list of known ciliary components (47) . Filamins crosslink cortical actin filaments into a dynamic 3D structure, and are thought to function as a signaling scaffold for a variety of cellular processes. Filamin A has been shown to be important for stability of meckelin and polycystin-2 (48,49), and FLNA loss leads to basal body positioning and ciliogenesis defects (48) . The meckelin-filamin A interaction may additionally be required to maintain correct levels of Wnt signaling.
Ciliogenesis is also defective in PLD in comparison to healthy tissues. Normal biliary ducts have solitary, cylindrical primary cilia on virtually all cells, with a length >4 mm. In medium-sized hepatic cysts (1-3 cm diameter) cilia are short (1.25 6 0.29 lm) and rare (1/200 cells), and the organelles are absent from larger cysts (>3 cm diameter) (50, 51) . Our findings indicate that loss of PRKCSH and SEC63 may lie at the root of these ciliary abnormalities. Both H69 and HEK293T cells with loss of these genes display a significant decrease in cilium formation under proliferative and serum-starvation conditions. This implicates structural ciliary abnormality in addition to previously found functional abnormality (12) (13) (14) in ADPLD cells.
In conclusion, our results suggest that loss of PRKCSH and SEC63 leads to general defects in ciliogenesis, while quenching of the Wnt signaling cascade is cholangiocyte-restricted. Interactions of all three PLD-associated protein complexes with FLNA may mark a common link between the ADPLD proteins and the cystogenic processes driving this disease. 
Materials and Methods
CRISPR-Cas9 gene knockout
For generation of PRKCSH, SEC63 and LRP5 mutant cell lines, we developed CRISPR-Cas9 constructs based on the pSpCas9(BB)-2A-GFP plasmid. pSpCas9(BB)-2A-GFP (PX458) was a gift from Feng Zhang (Addgene, Cambridge, USA; plasmid # 48138) (52) . This plasmid contains a mammalian-codon optimized Cas9 with nuclear targeting sequences, a gRNA backbone, and enhanced green fluorescent protein (eGFP) for selection. We designed oligo pairs of 20-nt on 'http://tools.genome-engineering. org' (Table 2) , which provides a score from 0 to 100 based on the specificity of target sites. We annealed oligos and ligated them into PX458 plasmid, and subsequently transformed them into competent E. coli. We screened plasmids from two E. coli clones per construct using Sanger sequencing. Verified constructs were transfected into HEK293T and H69 cells in 6-wells plate using FuGene HD (Promega, Madison, USA).
Selection of knockout cells
We sorted single GFPþ cells into a 96 well's plate using FACS on an Aria SORP sorter (BD Biosciences, San Jose, CA, USA). Remaining H69 cells were additionally seeded to a 6-well's plate, and we used 50% filtered, conditioned medium from 70% confluent H69 cells to improve their growth rate. From the 6-well's plate, we transferred clones individually onto a 96-well's plate after 2-3 weeks. We conducted Sanger sequencing for targeted regions, as well as western blot of protein products to confirm knockouts.
For both cell lines, we screened 15 clones per construct for mutations at a DNA and protein level. For experiments, we selected two PRKCSH -/-or SEC63 -/-clones per construct, and validated loss of protein expression on western blot in duplo.
DNA isolation and genotyping
We screened clones for mutations in PRKCSH, SEC63 and LRP5 using direct sequencing as described previously (7). Briefly, we isolated DNA from trypsin-detached cells using the PureGene DNA isolation kit (Gentra Systems/Qiagen, Minneapolis, USA) or High Pure PCR template preparation kit (Roche, Mannheim, Germany), and stored it at 4 C. Polymerase chain reaction (PCR) amplified PRKCSH, SEC63 and LRP5 exons with specific primers (Supplementary Material, Table S3 ).
DNA constructs
We generated entry clones encoding full-length human PRKCSH, SEC63 and LRP5 from cDNA from liver tissue; 528, 760 and 1615 amino acids respectively [NCBI Reference Sequence: NM_002743.3 (PRKCSH); NP_001001329.1 (PRKCSH), NM_007214.4 (SEC63), NP_009145.1 (SEC63); NM_002335.3 (LRP5); NP_001278831.1 (LRP5). We isolated total RNA from liver tissue using TRIzol Reagent (Life Technologies, Carlsbad, USA), and produced oligo dT cDNA by RT Transcriptor First Strand cDNA synthesis kit (Roche Applied Sciences, Mannheim, Germany). Full-length PCR fragments were obtained using the Faststart High Fidelity PCR System (Roche) using primers from Supplementary Material, Table S4 . Fragments were cloned into the Gateway entry vector pDONR201 (Life Technologies). LRP5 intracellular (ICD) fragment constructs, encoding the C-terminal amino acids 1409-1615 were generated using the LRP5 full-length entry clone as a template. LRP5ICD was added to the experiments to improve protein complex capture. Removing the transmembrane portion of proteins generally increases (water-soluble) protein yield. We made expression constructs from all entry clones using Gateway cloning procedures (Life Technologies) according to the manufacturer's protocol in N-and C-teminal TAP expression vectors. LRP5 mutant constructs were previously generated using the Quick Change-II-XL Site-Directed Mutagenesis Kit (Agilent Technologies, Santa Clara, USA) and a pcDNA3.1V5His WT-LRP5 as a template (Supplementary Material, Table S2 ) (2). Sequences were confirmed by Sanger sequencing.
Immunostaining and western blotting
We transfected plasmids expressing cTAP-PRKCSH, nTAP-SEC63, nTAP-LRP5 and nTAP-LRP5ICD in H69 and HEK293T cells with FuGene HD (Promega). We lysed cells using lysis buffer (50 mm Tris-HCl (pH7.5), 150 mm NaCl, 1% NP-40) on ice with complete protease inhibitor cocktail (Roche) 48 hours after transfection. Cells were spun down after 10 minutes incubation on ice and supernatant was collected. Sample Buffer (4x NuPAGE) was added to the supernatant and heated for 10 min at 70 C. Samples were run on NuPAGE Novex 4-12% Bis-Tris SDS-PAGE gels. We performed immunostainings with anti-Flag, anti-PRKCSH, or anti-SEC63 as well as with anti-alpha tubulin as primary antibodies (conditions shown in Supplementary Material, Table S5 ), and goat anti-rabbit IRDye800 and goat anti-mouse IRDye680c as a secondary antibodies (1 mg/ml, Molecular Probes, Waltham, USA). DAPI was included to stain nuclei. Washing steps used PBS-Tween (PBS with 0.2% Tween 20). We kept western blots in the dark and scanned them on an Odyssey infrared imaging system (Li-Cor, Lincoln, USA). Bands were detected and processed by ODYSSEY application software (Version 1.2, Li-Cor).
Cell culture and DNA transfection HEK293T were cultured in high glucose DMEM AQmedia (Sigma Aldrich, St. Louis, USA), supplemented with 10% FCS, 1% penicillin/streptomycin, 1 mM sodium pyruvate, and 10 mM HEPES. H69 cells were cultured in DMEM/F12, supplemented with 10% FCS, 1% penicillin/streptomycin and 10 mM HEPES. For DNA transfections, HEK293T and H69 cells were seeded, grown overnight, and then transfected using FuGene HD (Promega).
Tandem affinity proteomics and mass spectrometry
Cells transiently expressing the Streptavidin-FLAG (SF-TAP)-tagged PRKCSH (cTAP), SEC63 (nTAP) and LRP5 (nTAP, ICD) fusion proteins were lysed on ice with complete protease inhibitor cocktail (Roche Diagnostics) in lysis buffer (50 mm Tris-HCl (pH 7.5), 150 mm NaCl, 1% NP-40). The Streptavidin-and FLAG based tandem affinity purification steps were performed as previously described (53, 54) . 5% of the final eluate was evaluated by SDS-PAGE followed by silver staining, according to standard protocols, while the remaining 95% was subjected to protein precipitation with chloroform and methanol. Protein precipitates were subsequently subjected to mass spectrometry analysis and peptide identification as previously described (55) .
Proteins identified in SF-TAP control experiments (empty SF-TAP vector), or identified in more than 15% of the experiments from our in-house TAP-proteome data collection (33) , were removed as nonspecific complex members. Protein interaction networks were visualized by Cytoscape software (56) .
Immunofluorescence and microscopy
We cultured HEK293T and H69 cells on poly-L-lysine coated glass slides under standard cell culture conditions in Dulbecco's modified Eagle's medium (DMEM) or DMEM/Ham's F12 with 10% fetal calf serum (FCS). Serum-starved medium (H69:Opti-MEM1; HEK293T:DMEM/PBS 1:1) induced cilia for 72 h prior to staining. Subsequently, we fixated cells in 3.8% paraformaldehyde in phosphate buffered saline (PBS) and permeabilized with 1% Triton-X-100 in PBS. We blocked cells with freshly made 2% bovine serum albumin (BSA) in PBS for 1 h, followed by 1 h incubation with primary antibodies (in 2% BSA in PBS) at room temperature. We washed cells with PBS, and added secondary antibodies at room temperature for 30 min. We used the following primary antibodies: anti-PRKCSH, anti-SEC63, anti-PDI, anti-ARL13B, anti-FLAG, anti-peroxisomal biogenesis factor 14, anti-alpha-tubulin and anti-beta-actin (Supplementary Material, Table S5 ). Secondary antibodies (all from Life Technologies) were: anti-rabbit IgG Alexa Fluor 488, and antimouse IgG Alexa Fluor 568 (Supplementary Material, Table S6 ). We protected glass slides with stained cells with Vectashield (Vector Laboratories, Burlingame, CA) and placed them on a microscopic glass slide. We performed microscopy on an Axio Imager ZI fluorescence microscope (Zeiss, Sliedrecht, The Netherlands) with an ApoTome slider. We processed images using AxioVision (Zeiss) software, and we assessed three images per experiment. Percentages of ciliated cells are depicted as mean 6 S.D.
Cell cycle analysis
Cell cycle analysis was performed with HEK293T wild type cells, 2 PRKCSH knock-out cell lines and a SEC63 knock-out cell line in log phase. Approximately 1Â 10 6 cells were collected using trypsin and the cells were washed with PBS. The cells were fixed by adding 70% ethanol to the cell pellet while mixing and incubated for 1 h at 4 C. The cells were then washed with PBS at 850Â g and 1 ml of Propidium Iodide working solution (40 mg/mL PI and 100 mg/mL RNase A in PBS)was added to the cells. After an incubation of 30 minutes at 37 C cells were measured with the FC500 flowcytometer (Beckman-Coulter, Indianapolis, IN) with excitation at 488 nm (15 mW) and emission at 610 nm longpass filter. The first peak represents the G1 phase, the second peak the G2 phase and in between the S phase.
(De)glycosylation assay
To check whether PRKCSH and SEC63 can influence the maturation and expression of LRP5, HEK293T wild type cells, 2 PRKCSH knock-out cell lines and a SEC63 knock-out cell line were transiently transfected with the pcDNA3.1V5His WT-LRP5 construct because of the low endogenous LRP5 expression in HEK293T cells. After 48 h cells were lysed with lysis buffer (50 mm Tris-HCl (pH 7.5), 150 mm NaCl, 1% NP-40, 0.1% SDS) on ice with complete protease inhibitor cocktail (Roche). Total protein was subjected to Endoglycosidase H or N-Glycosidase F (Roche) treatment according the manufacturers manual. 20 Micrograms of treated and nontreated total protein samples were subsequently analyzed using SDS-PAGE followed by western blotting. LRP5 was visualized by the Clarity ECL-kit (Bio-rad Laboratories, Hercules, CA) using the primary V5-antibody (Life Technologies) and the secondary rabbit anti-mouse-HRP antibody (Dako; Glostrup, Denmark).mRNA levels of the cell lines were analyzed by isolating RNA using TRIZOL (Life Technlogies) according the manufacturers manual. cDNA was produced using iScript cDNA Synthesis Kit (Bio-rad). Real time PCR was performed in triplicate with SybrGreen using primers LRP5 forward ( 
Wnt luciferase activity assays
We performed Wnt luciferase assays as described previously (2) . For the activity assay, we seeded 5.0 Â 10 3 HEK293T cells, or 5.0 Â 10 3 human cholangiocyte 69 (H69) cells per well in a 96-well plate in triplicate. After 24 h, we transiently transfected cells using FuGene HD (Promega) with 100 ng LRP5 construct or empty vector and 100 ng of TCF/LEF1 Reporter or 100 ng negative control according to the manufacturers' instructions (Cignal TCF/LEF1 Reporter Assay Kit; Qiagen). Twenty-four hours after transfection, medium was replaced by medium with or without 50% Wnt3a conditioned medium to initiate Wnt signaling. We cultured cells for another 24 h, and detected luciferase activity using the Dual-Glo Luciferase Assay System (Promega) in an InfiniteM200-Pro plate reader (Tecan, Mä nnedorf, Switzerland). Firefly luciferase activity was normalized to Renilla luciferase activity to correct for variations in transfection efficiencies. Values are reported as means 6 S.E.M. Each experiment was conducted in triplicate. Scores indicate target site specificity on a scale from 1 to 100, higher scores are more specific.
*Target site found in sequence following ATG/start codon.
RNA isolation and RT-qPCR
Total RNAs were isolated using TRIzol according to the manufacturer's protocol. We reverse transcribed RNA into complimentary DNA (cDNA) using a iScript cDNA synthesis kit according to the protocol (Bio-Rad, Hercules, USA). 1 ml of resulting cDNA was used for RT-qPCR. Briefly, the RT-qPCR was carried out on an thermal cycler (CFX96, Bio-Rad), using the 2ÀDDCt SYBR green protocol (57) . We amplified axin 2 and beta-2-microglobulin (reference) in 40 cycles. RT-qPCR data were analyzed using the CFX-Manager software, which validates primer quality by analyzing melting curves. All the RT-qPCRs were repeated three times with triplicates for each treatment. For RT-PCR, all values were represented as mean 6 S.D.
Statistical analysis
For cilia measurements, luciferase assays, and RT-qPCR we used Mann-Whitney test to test for significance. A two-tailed P-value of <0.05 was considered significant.
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